BONUSCAP-ZERTIFIKAT - PFIZER INC | Real-time BOERSE MUENCHEN 07:46:56 2024-05-28 am EDT | ||
| 39.01 EUR | -0.36% |
|
| Current month | +37.66% | ||
| 1 month | +38.98% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
Latest news about PFIZER, INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-05-28 | 39.01 | -0.36% |
| 24-05-27 | 39.15 | +1.06% |
| 24-05-24 | 38.74 | -0.08% |
| 24-05-23 | 38.77 | -2.69% |
| 24-05-22 | 39.84 | +3.16% |
Real-time BOERSE MUENCHEN
Last update May 28, 2024 at 07:46 am EDT
More quotesStatic data
| Product type | Bonus- and Part-Guarantee-Certificates |
|---|---|
| Buy / Sell | CALL |
| Underlying | PFIZER, INC. |
| Issuer | 
UniCredit
|
| WKN | HD3TXL |
| ISIN | DE000HD3TXL0 |
| Date issued | 2024-03-18 |
| Strike | 45 $ |
| Maturity | 2024-12-20 (206 Days) |
| Parity | 1 : 1 |
| Emission price | 34.61 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 40.35 € |
|---|---|
| Lowest since issue | 27.76 € |
| Spread | 0.02 € |
| Spread % | 0.05% |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.88
USD
Average target price
31.92
USD
Spread / Average Target
+10.51%
- Stock Market
- Certificates
- Certificat
